Lipella Pharmaceuticals I... (LIPO)
NASDAQ: LIPO
· Real-Time Price · USD
0.63
-0.01 (-1.52%)
At close: Aug 15, 2025, 11:05 AM
-1.52% (1D)
| Bid | 0.63 |
| Market Cap | 2.81M |
| Revenue (ttm) | 129.78M |
| Net Income (ttm) | -1.31B |
| EPS (ttm) | -4.12 |
| PE Ratio (ttm) | -0.15 |
| Forward PE | -0.03 |
| Analyst | Buy |
| Ask | 0.64 |
| Volume | 450 |
| Avg. Volume (20D) | 33,195 |
| Open | 0.64 |
| Previous Close | 0.64 |
| Day's Range | 0.63 - 0.64 |
| 52-Week Range | 0.55 - 7.31 |
| Beta | -0.09 |
About LIPO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LIPO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LIPO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
+41.64%
Lipella Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
6 months ago
+80.23%
Lipella Pharmaceuticals shares are trading higher after the company received FDA approval for an expanded access program for LP-310 in oral lichen planus.
